PULMONARY FIBROSIS, FAMILIAL (TELOMERE BIOLOGY DISORDER)

Clinical trials for PULMONARY FIBROSIS, FAMILIAL (TELOMERE BIOLOGY DISORDER) explained in plain language.

Never miss a new study

Get alerted when new PULMONARY FIBROSIS, FAMILIAL (TELOMERE BIOLOGY DISORDER) trials appear

Sign up with your email to follow new studies for PULMONARY FIBROSIS, FAMILIAL (TELOMERE BIOLOGY DISORDER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human trial aims to lengthen telomeres, offering hope for rare genetic diseases

Disease control Recruiting now

This early-stage trial is testing whether a combination of two oral compounds (deoxycytidine and deoxythymidine) is safe for people with rare genetic disorders called telomere biology disorders. These disorders cause very short telomeres (protective caps on chromosomes), leading …

Matched conditions: PULMONARY FIBROSIS, FAMILIAL (TELOMERE BIOLOGY DISORDER)

Phase: PHASE1 • Sponsor: Suneet Agarwal • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

PULMONARY FIBROSIS, FAMILIAL (TELOMERE BIOLOGY DISORDER)

Get alerted when new PULMONARY FIBROSIS, FAMILIAL (TELOMERE BIOLOGY DISORDER) trials appear

First human trial aims to lengthen telomeres, offering hope for rare genetic diseases